MedTrace Logo

Digital Tool Enhancing GPs' Information Management for Patients with Multimorbidity - a Pilot Study

NCT06061172 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 123

Last updated 2024-12-12

No results posted yet for this study

Summary

The gp-multitool.de study is a cluster-randomized controlled trial that aims to enhance evidence-based and patient-centered care for patients with multimorbidity by assessing and providing information relevant for the primary care of this patient group. This pilot study examines the feasibility of the gp-multitool.de study, i.e., intervention and evaluation in GP practices in urban and rural administrative districts in Germany.

Conditions

  • Asthma
  • Breast Neoplasms
  • Coronary Disease
  • Diabetes Mellitus, Type 1
  • Diabetes Mellitus, Type 2
  • Pulmonary Disease, Chronic Obstructive
  • Comorbidities and Coexisting Conditions

Interventions

OTHER

gp-multitool.de

The intervention is based on a digital tool, which implements recommendations of the S3 guideline "multimorbidity" of the German College of General Practitioners and Family Physicians. The tool includes nine questionnaires addressing four dimensions of care: 1. preferences (including a. treatment goals, and b. involvement of other persons in decision making); 2. activities (including a. activities and participation, and b. social support); 3. treatment (including a. problems with medication, and b. treatment burden); 4. complaints (including a. pain, b. psychiatric disorders, and c. other complaints). The GPs can send the questionnaires by email to the patients and the patients can fill out the questionnaires at their home or in the waiting room of the GP's practice using their own smartphones, tablets or computers. The digital tool also includes instructions for conducting a medication review. Results from talks between GPs and patients can be documented in the tool.

Sponsors & Collaborators

  • Universitätsklinikum Hamburg-Eppendorf

    lead OTHER

Principal Investigators

  • Ingmar Schäfer, PD Dr. · Universitätsklinikum Hamburg-Eppendorf

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-02
Primary Completion
2024-08-29
Completion
2024-08-29

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06061172 on ClinicalTrials.gov